← Back to home

SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY

Clinical trials for SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY explained in plain language.

Never miss a new study

Get alerted when new SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY trials appear

Sign up with your email to follow new studies for SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New injection aims to help sleep apnea patients breathe easier and lose weight

Disease control Recruiting now

This study is testing whether a new injectable medication called HRS9531 can help people who have both obesity and obstructive sleep apnea. The trial will involve 140 adults who are already using a CPAP machine for their sleep apnea. Researchers will measure if the injection redu…

Matched conditions: SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY

Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY

Get alerted when new SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY trials appear

New injection aims to help sleep apnea patients breathe easier and lose weight